About this trial
Study of the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and comparaison with others inflammatories diseases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having 18-FDG PET-CT between 2012 and 2024
Diagnosis of inflammatory rheumatism by specialist doctor
Adult without opposition to use there data for research
Affiliate to social security system
Disqualifiers
Refusal participation
Patient under juridic protection
Trial population
Adult with inflammatory rheumatism confirmed by specialist, with or without treatment and having a 18-FDG-PET CT.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Diagnostic performance of 18-FDG PET scores for diagnostic of Polymyalgia rheumatica.
Evaluation of the metabolism of mains joints compared to liver. Calculation of different scores described in literature.
Secondary outcomes
Analysis of SUV and visual fixation of mains joints.
Measure of SUV of mains joints and evaluation of the fixation compared to liver.
Diagnostic performance of 18-FDG PET scores for diagnostic of others inflammatory rheumatism.
Evaluation of the precedent scores for diagnosis of others rheumatisms. Creation of others scores if some joints seem to be interesting.
Comparaison of scores with clinical, biological and radiological data.
Search for correlation between scores and symptoms, blood test or CT/MRI exams.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: